NTRA Q4 2022 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q4 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$217M+25.6% YoY

Gross Profit

$90M41.4% margin

Operating Income

-$142M-65.3% margin

Net Income

-$143M-65.6% margin

EPS (Diluted)

$-1.45

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$93M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$689M

Stockholders' Equity

$706M

Cash & Equivalents

$466M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$217M	$173M	+25.6%
Gross Profit	$90M	$79M	+14.0%
Operating Income	-$142M	-$140M	-1.5%
Net Income	-$143M	-$141M	-1.4%

Revenue Segments

Product

$213M98%

Licensing and other

$4M2%

Geographic Segments

United States

$210M98%

Asia Pacific and Other

$2M1%

Americas, excluding U.S.

$1M1%